text.skipToContent text.skipToNavigation

QIAsymphony PAXgene Blood ccfDNA Kit

For purification of ccfDNA from plasma using the QIAsymphony SP

  • Optimized chemistry and input volumes for PAXgene Blood ccfDNA Tubes
  • Separate protocol lines for small (STA) and large (LAF) ccfDNA fragments
  • Prefilled reagent cartrdiges with bar code for safety and ease of use
  • Standardized processing for high reproducibility

 


The PAXgene Blood ccfDNA System consists of a blood collection tube (PAXgene Blood ccfDNA Tube) and a ccfDNA purification kit for the QIAsymphony (QIAsymphony PAXgene Blood ccfDNA Kit).
Cat No./ID: 768536
QIAsymphony PAXgene Blood ccfDNA Kit (192)

Reagent cartridges, accessories and proteinase K vials for 192 preps

仅限于科研应用,不适用于诊断,不为疾病的诊断、预防或治疗提供参考信息。


0
Isolated ccfDNA is compatible with methylation-specific downstream applications.

Whole blood of 4 healthy donors was collected into either EDTA or PAXgene Blood ccfDNA Tubes. Blood was left at room temperature for up to 7 days. Each day, ccfDNA was isolated from samples, bisulphite converted (Epitect FAST kit, QIAGEN) and analyzed with the GEMINI assay (Clinical Genomics) based on 2 methylated (BCAT1 and IKZF1) and 1 control (ACTB) target. Three PCR replicates per target sequence were analyzed. ccfDNA from blood stored in EDTA tubes generated more false positives than from blood stored in PAXgene Blood ccfDNA Tubes (data courtesy of Clinical Genomics).

1
Two protocol lines of the QIAsymphony PAXgene Blood ccfDNA Kit for different research needs.

With the standard protocols (STA), predominantly small ccfDNA fragments are isolated. The large fragment protocols (LAF) efficiently co-purify large and small ccfDNA fragments. Both protocol lines consist of one protocol for 2.4 ml and one protocol for 4.8 plasma input.

2
PCR results from blood collected in PAXgene Blood ccfDNA Tubes remain stable over storage time.

The change in delta-CT values of target versus control signal for ccfDNA isolated from whole blood stored in EDTA and PAXgene Blood ccfDNA Tubes was measured at different storage intervals. Shown are the relative signals of the 3 mutations covered by the therascreen EGFR assay: [A] point mutation T790M, [B] deletion in exon 19 and [C] L858R. Each PCR was done in duplicate. To calculate the delta-CT value, the average CT of each mutant was subtracted from the average CT of the wildtype sub-assay. The average of all donors is shown in the figure for all tested time points. The therascreen EGFR assay defines a threshold for each sub-assays. Delta-CT values above this threshold result in false-negative calls. Results from the ccfDNA isolated from EDTA tubes exceeded this threshold over time whereas results from the PAXgene Blood ccfDNA Tubes remained stable.

3
The QIAsymphony SP processes samples containing magnetic particles.

A magnetic rod protected by a rod cover enters a well containing the sample and attracts the magnetic particles. The magnetic rod cover is positioned above another well and the magnetic particles are released. The QIAsymphony SP uses a magnetic head with an array of 24 magnetic rods, and can therefore process up to 24 samples simultaneously. Collection, transfer and release of magnetic particles is repeated several times during sample processing.

4
High performance, comparable to QIAamp Circulating Nucleic Acid Kit.

Results from two studies assessing the performance of the QIAsymphony PAXgene Blood ccfDNA Kit. Study A compares ccfDNA yield and portion of double-stranded DNA of eluates generated with the QIAsymphony PAXgene Blood ccfDNA Kit to eluates from the manual QIAamp Circulating Nucleic Acid Kit. Study B summarizes performance parameters for the PAXgene ccfDNA system. The QIAsymphony PAXgene Blood ccfDNA Kit provides consistently accurate results.

Performance

The fully automated QIAsymphony PAXgene Blood ccfDNA Kit procedure generates ccfDNA yields comparable to the manual QIAamp Circulating Nucleic Acid Kit procedure (see figure High performance, comparable to QIAamp Circulating Nucleic Acid Kit). Since yield is strongly dependent of donor, individual yields may vary. Onboard measures of the QIAsymphony SP minimize cross-contamination.

Principle
Apoptosis and lysis of white blood cells in unstabilized whole blood releases genomic DNA into plasma, which dilutes naturally occurring ccfDNA. PAXgene Blood ccfDNA Tubes contain an additive that prevents blood coagulation and immediately stabilizes blood cells via a non-crosslinking stabilization solution (see figure PCR results from blood collected in PAXgene Blood ccfDNA Tubes remain stable over storage time). This impedes the release of intracellular DNA and maintains constant ccfDNA levels in plasma. When used with PAXgene Blood ccfDNA Tubes, the proven magnetic particle technology of the QIAsymphony PAXgene Blood ccfDNA Kit provides a rapid, automated procedure to isolate ccfDNA of high quality and purity (see figure Isolated ccfDNA is compatible with methylation-specific downstream applications).
Procedure

The workflow begins with a centrifugation step that separates plasma from the cellular fraction of the whole blood collected into PAXgene Blood ccfDNA Tubes. The plasma is then carefully transferred into a second tube. A second centrifugation step can be carried out optionally to remove any traces of buffy coat. The pure plasma is then transferred to a third tube which is loaded into the QIAsymphony SP.

In the QIAsymphony SP, plasma proteins are digested by proteinase K while ccfDNA binds to the surface of magnetic beads (see figure The QIAsymphony SP processes samples containing magnetic particles). Depending on the chosen protocol line, predominantly small ccfDNA fragments (STA protocol line) or small and large ccfDNA fragments (LAF protocol line) are isolated. Three wash steps ensure contaminant removal. Finally, ccfDNA is eluted from the magnetic particles and is ready for use in downstream applications (see figure Two protocol lines of the QIAsymphony PAXgene Blood ccfDNA Kit for different research needs).

Applications

ccfDNA purified using the QIAsymphony PAXgene Blood ccfDNA Kit and the QIAsymphony SP is ready for use in a wide range of downstream applications, including:

  • PCR, digital, multiplex and quantitative real-time PCR 
  • Pharmacogenomic studies 
  • SNP genotyping
  • Next generation sequencing
  • Methylation assays

 

Features
Specifications
应用 PCR, qPCR, real-time PCR, blotting, genotyping
洗脱体积 1 ml
规格 Processing tube
上样体积 Whole blood
处理 Manual (centrifugation)
Shelf life 150–500 µg
通量 8.5 ml
Time per run 96 samples of 4.8 ml plasma in 5 h 40 min

您无权限查看此资源

常见问题 (31)
FAQ ID - 3626
浏览
FAQ ID - 3633
浏览
FAQ ID - 3641
浏览
FAQ ID - 3642
浏览
FAQ ID - 3643
浏览
FAQ ID - 3644
浏览
FAQ ID - 3645
浏览
FAQ ID - 3646
浏览
FAQ ID - 3648
浏览
FAQ ID - 3649
浏览
FAQ ID - 3650
浏览
FAQ ID - 3652
浏览
FAQ ID - 3653
浏览
FAQ ID - 3654
浏览
FAQ ID - 3656
浏览
FAQ ID - 3657
浏览
FAQ ID - 3651
浏览
FAQ ID - 3658
浏览
FAQ ID - 3655
浏览
FAQ ID - 3628

浏览
FAQ ID - 3629
浏览
FAQ ID - 3631
浏览
FAQ ID - 3632
浏览
FAQ ID - 3634
浏览
FAQ ID - 3635
浏览
FAQ ID - 3636
浏览
FAQ ID - 3640
浏览
FAQ ID - 3639
浏览
FAQ ID - 3638
浏览
FAQ ID - 3630
浏览
FAQ ID - 3637
浏览
应用与实验方案 (1)
For purification of ccfDNA from human whole blood stabilized in PAXgene Blood ccfDNA Tubes using the QIAsymphony SP and QIAsymphony PAXgene Blood ccfDNA Kit.

 


显示更多
试剂盒操作手册 (1)
For purification of ccfDNA from plasma using the QIAsymphony SP
显示更多
fragment fix placeholder